Viewing Study NCT00080002


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:33 AM
Study NCT ID: NCT00080002
Status: TERMINATED
Last Update Posted: 2012-09-06
First Post: 2004-03-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
Sponsor: Enzon Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module